BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25575479)

  • 1. New hypothesis and treatment targets of depression: an integrated view of key findings.
    Cai S; Huang S; Hao W
    Neurosci Bull; 2015 Feb; 31(1):61-74. PubMed ID: 25575479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The P11, tPA/plasminogen system and brain-derived neurotrophic factor: Implications for the pathogenesis of major depression and the therapeutic mechanism of antidepressants.
    Tsai SJ
    Med Hypotheses; 2007; 68(1):180-3. PubMed ID: 16890384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(1):145-8. PubMed ID: 17196755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain derived neurotrophic factor and influences of stress in depression.
    Kimpton J
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S169-71. PubMed ID: 22945215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals - a proof of concept study.
    Sheldrick A; Camara S; Ilieva M; Riederer P; Michel TM
    Eur Psychiatry; 2017 Oct; 46():65-71. PubMed ID: 29102768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory cytokines, growth factors, and depression.
    Lotrich F
    Curr Pharm Des; 2012; 18(36):5920-35. PubMed ID: 22681170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol and depression: three questions for psychiatry.
    Herbert J
    Psychol Med; 2013 Mar; 43(3):449-69. PubMed ID: 22564216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF in sleep, insomnia, and sleep deprivation.
    Schmitt K; Holsboer-Trachsler E; Eckert A
    Ann Med; 2016; 48(1-2):42-51. PubMed ID: 26758201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of brain-derived neurotrophic factor in mood disorders.
    Hashimoto K; Shimizu E; Iyo M
    Brain Res Brain Res Rev; 2004 May; 45(2):104-14. PubMed ID: 15145621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels.
    Tsai SJ
    Med Hypotheses; 2006; 67(5):1185-8. PubMed ID: 16797865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
    Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
    J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and major depression.
    Marazziti D; Rutigliano G; Baroni S; Landi P; Dell'Osso L
    CNS Spectr; 2014 Aug; 19(4):293-304. PubMed ID: 24103843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New understanding of mechanisms of action of bipolar medications.
    Sanacora G
    J Clin Psychiatry; 2008; 69 Suppl 5():22-7. PubMed ID: 19265637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression.
    Kunugi H; Hori H; Adachi N; Numakawa T
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):447-59. PubMed ID: 20923424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of the BDNF-dependent pathway in treatment-emergent suicidality or decreased response to antidepressants.
    Tsai SJ
    Med Hypotheses; 2005; 65(5):942-6. PubMed ID: 16002234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory mechanisms in major depressive disorder.
    Raedler TJ
    Curr Opin Psychiatry; 2011 Nov; 24(6):519-25. PubMed ID: 21897249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.
    Kopschina Feltes P; Doorduin J; Klein HC; Juárez-Orozco LE; Dierckx RA; Moriguchi-Jeckel CM; de Vries EF
    J Psychopharmacol; 2017 Sep; 31(9):1149-1165. PubMed ID: 28653857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Major depressive disorders and BDNF (brain-derived neurotrophic factor)].
    Shimizu E; Hashimoto K; Iyo M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):147-50. PubMed ID: 15291244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide: Antidepressant mechanisms and inflammation.
    Ghasemi M
    Adv Pharmacol; 2019; 86():121-152. PubMed ID: 31378250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.